Nurix Therapeutics discovers drugs that harness the body’s natural process to control protein levels.

Our drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells, as a unique therapeutic approach to treat a broad range of diseases.

Our focus is on developing drugs to treat cancer including novel, small molecule immuno-oncology agents.

Company Information

April 20, 2022